Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state  by Pinheiro, Melina B. et al.
Cytokine 62 (2013) 165–173Contents lists available at SciVerse ScienceDirect
Cytokine
journal homepage: www.journals .e lsev ier .com/cytokineSevere preeclampsia goes along with a cytokine network disturbance
towards a systemic inﬂammatory state
Melina B. Pinheiro a,b, Olindo A. Martins-Filho c, Ana Paula L. Mota a, Patrícia N. Alpoim a,
Lara C. Godoi a, Amanda C.O. Silveira c, Andrea Teixeira-Carvalho c, Karina B. Gomes a, Luci M. Dusse a,⇑
aDepartamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
b Faculdade de Medicina, Universidade Federal de São João Del Rei, Minas Gerais, Brazil
c Laboratório de Biomarcadores de Diagnóstico e Monitoração, Centro de Pesquisas René Rachou, Fundação Osvaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
a r t i c l e i n f oArticle history:
Received 31 October 2012
Received in revised form 16 February 2013
Accepted 23 February 2013
Available online 21 March 2013
Keywords:
Preeclampsia
Cytokines
Inﬂammation1043-4666  2013 Elsevier Ltd.
http://dx.doi.org/10.1016/j.cyto.2013.02.027
⇑ Corresponding author. Address: Departamento de
gicas, Faculdade de Farmácia, Universidade Federal d
Carlos, 6627, Pampulha, CEP: 31270-901, Belo Horizon
+55 31 3409 6880/6900; fax: +55 31 3409 6985.
E-mail address: lucidusse@gmail.com (L.M. Dusse)
Open access under the Ela b s t r a c t
Although preeclampsia causes high maternal/fetal morbidity and mortality, the etiology of this multi-
system disorder still remains to be elucidated. Herein, we have characterized the cytokine plasma levels
in severe preeclamptic women compared to normotensive pregnant and non-pregnant women, aiming to
better understand the immunological network and its clinical signiﬁcance for the pathogenesis and
severity of preeclampsia. A total of 219 women were selected. The study population was composed of
three groups referred as severe preeclamptic, normotensive pregnant and non-pregnant women. Cyto-
kine plasma levels were determined using commercially available kits, Cytometric Beads Array – CBA
to quantify TNF-a, IFN-c, IL-4, IL-5, IL-10, IL-1b, IL-6, IL-8 and IL-12. Our ﬁndings demonstrated that
severe preeclamptic state is associated with high levels of pro-inﬂammatory cytokines IL-8, IL-6, and
IFN-c (P < 0.05 for all) whereas normotensive pregnancy evolves high levels of regulatory cytokine IL-
10 (P < 0.05). Moreover, an outstanding pro-inﬂammatory ‘‘cytokine signature’’ could be observed in
severe preeclamptic women display, while an overall regulatory state is the hallmark for normotensive
pregnancy. In summary, our data showed that elevated levels of pro-inﬂammatory cytokines in the
maternal circulation with a deviation in the ‘‘IL-8  IL-6’’ axis towards IFN-c might drive the cytokine
network in preeclamptic women towards an excessive systemic inﬂammatory state.
 2013 Elsevier Ltd.Open access under the Elsevier OA license.1. Introduction
Preeclampsia (PE) is a multifactorial disease characterized by
systolic blood pressure P140 mmHg or diastolic P90 mmHg at
bed rest on at least two occasions 6 h apart, and proteinuria
P0.3 g/24 h, measured after the 20th week of pregnancy [1]. Clini-
cally, it is important to diagnose the severe form of PE when hyper-
tension and proteinuria are even higher. This form can progress to
eclampsia (characterized by seizures as a sign of affection of the
cerebral vessels), HELLP syndrome (hemolysis, elevated liver en-
zyme, low platelets) or disseminated intravascular coagulation [2].
Although PE causes high maternal/fetal morbidity and mortal-
ity, the etiology of this multi-system disorder still remains to be
elucidated.
It is well established that the physiological balance between
pro-inﬂammatory/regulatory responses presents importantAnálises Clínicas e Toxicoló-
e Minas Gerais, Av. Antonio
te, Minas Gerais, Brazil. Tel.:
.
sevier OA license.changes in healthy pregnancy, with a shift toward a regulatory
state [3]. In PE it has been proposed that this alteration does not
occur, or it is reverted in very early stages of the disease, and in
consequence, it leads to a pro-inﬂammatory state. Previous studies
showed increased levels of IFN-c and decreased levels of IL-4 [4–7].
On the other hand, regarding to TNF-a, IL-1b, IL-6, IL-8, and IL-10
conﬂicting results have been found [7–13].
In the present investigation, we have characterized the wide
cytokine proﬁle in severe preeclamptic women, compared to nor-
motensive pregnant and non-pregnant women, aiming to better
understand the immunological network and its clinical signiﬁ-
cance for the PE pathogenesis and severity.2. Materials and methods
2.1. Study population
A total of 219 women were selected from Odete Valadares
Maternity-Belo Horizonte/Brazil, Regional Public Hospital of Be-
tim/Brazil and Healthy Center Guanabara, Betim/Brazil from 2009
to 2011. The study population was composed of three groups
166 M.B. Pinheiro et al. / Cytokine 62 (2013) 165–173referred as severe preeclamptic, normotensive pregnant and non-
pregnant women. The severe preeclamptic group comprises 69
women, age ranging from 14 to 44 years, with gestational age be-
tween 22 and 40 weeks. Severe PE was deﬁned by systolic blood
pressure P160 mmHg or diastolic blood pressure P110 mmHg,
on more than two consecutive occasions within 4 h apart and pro-
teinuria >2 g L1 or at least 2+ protein by dipstick. The group of
normotensive pregnant was composed by 69 women, age ranging
from 14 to 42 years, with gestational age between 20 and 41 weeks
with systolic/diastolic blood pressure below 120/80 mmHg and no
history of hypertension or proteinuria. Non-pregnant women, with
age ranging from 14 to 44 years, had no clinical and laboratory
alterations. No signiﬁcant differences were observed for age and
gestational age. As expected, signiﬁcant differences were observed
for body mass index (BMI), gestational weight gain (GWG) as well
as systolic (SBP) and diastolic blood pressures (DBP). Table 1 sum-
marizes the clinical characteristics of the study groups.
Exclusion criteria common for the three groups were chronic
hypertension, haemostatic abnormalities, cancer, diabetes, cardio-
vascular, autoimmune, renal, and hepatic diseases, anticoagulant
or corticosteroids therapy.
The Ethics Committee at Federal University of Minas Gerais-
Brazil approved this study and informed consent was obtained
from all participants. The research protocol did not interfere with
any medical recommendations or prescriptions.
2.2. Blood sampling
Five mL whole blood samples were drawn in EDTA-K3 1.8 mg/
mL (Vacuette) and centrifuged at 2500g for 20 min at 4 C to ob-
tain the plasma samples. Aliquots were stored at 70 C until use
for ﬂow cytometric cytokine measurements.
2.3. Cytometric beads array for cytokine measurements
Cytokine plasma levels were determined using commercially
available kits, including Human Th1/Th2 Cytometric Beads Array
– CBA (BD Biosciences Pharmingen, USA) to quantify TNF-a, IFN-
c, IL-4, IL-5 and IL-10 along with the Human Inﬂammation kit to
quantify IL-1b, IL-6, IL-8 and IL-12. The CBA immunoassay was car-
ried out according to the manufacturer instructions.
2.4. Analysis of ‘‘cytokine plasma levels’’ and ‘‘cytokine signatures’’
The cytokine plasma levels were analyzed as the mean ﬂuores-
cent intensity (MFI) provided by the CBA immunoassay. Addition-
ally, the analysis referred as ‘‘cytokine signatures’’ were also
performed as previously proposed by Luiza-Silva et al. [14]. Brieﬂy,
the global median value for each cytokine was used as the cut-off
edge to tag each women as they display ‘‘Low levels’’ ( for all
cytokines), ‘‘High levels of pro-inﬂammatory’’ ( for IL-8, IL-6,Table 1
Demographic and clinical characteristics of the three studied groups.
Parameters Non-pregnant Normotensi
Age (years) 25 (6.2) 24 (6.2)
GA (weeks) – 33 (20–41)
BMI (kg/m2) 21.80 (19.95–25.45) 23.30 (21.00
GWG (kg) – 10.0 (0.1–25
SBP (mmHg) 120 (80–130) 110 (90–130
DBP (mmHg) 80 (50–90) 70 (50–90)
GA: gestational age; GWG: gestational weight gain; SBP: systolic blood pressure; DBP:
Age is expressed as mean (SD) and data analysis performed by ANOVA followed by Tuk
GA, GWG, BMI, SBP and DBP are expressed as median (min–max) and data analysis per
* Statistic signiﬁcances at P < 0.05 are highlighted by: a non-pregnant vs PE; b non-pregIL-1b, TNF-a, IL-12, and IFN-c) or ‘‘High levels of regulatory’’ (
for IL-4, IL-5, and IL-10) cytokines. The frequency (%) of women
showing ‘‘High cytokine levels’’ was calculated and the ‘‘cytokine
signature’’ assembled as the ascendant frequencies in order to
identify changes in the overall cytokine patterns amongst the three
studied groups.
2.5. Statistical analysis
Demographic and clinical characteristic were compared
amongst subgroups by ANOVA followed by Tukey post-test. The
cytokine plasma levels, expressed as medium ﬂuorescence inten-
sity (MFI), were compared amongst subgroups by Kruskal–Wallis
followed by Dunn’s post-test. All analysis were performed using
the program GraphPad PRISM (version 5.0) and signiﬁcant differ-
ences, in all cases, considered at P < 0.05.
Additional strategy of data analysis was used to compare the
ascendant proﬁle referred as ‘‘cytokine signatures’’. Relevant dif-
ferences were considered when the frequency of patients with high
cytokine levels was above the 50th percentile. Spearman’s rank
correlations (rS) were computed to assess correlations between
inﬂammatory cytokines IL-8, IL-6, IL-1b, TNF-a and IFN-c in pre-
eclamptic women, normotensive pregnant and non-pregnant
women.3. Results
3.1. Severe preeclamptic state is associated with high levels of pro-
inﬂammatory cytokines IL-8, IL-6, and IFN-c whereas normotensive
pregnancy evolves with high levels of regulatory cytokine IL-10
The analysis of cytokine plasma levels for groups demonstrated
that the levels of IL-8, IL-6 and IFN-c were signiﬁcantly higher in
preeclamptic women as compared to non-pregnant women as well
as to non-pregnant women (Fig. 1). Moreover, the levels of TNF-a
were also signiﬁcantly higher in preeclamptic women in compari-
son with non-pregnant women. On the other hand, normotensive
pregnant showed signiﬁcantly higher levels of IL-10 as compared
to preeclamptic women and non-pregnant. No signiﬁcant differ-
ences were observed for plasma levels of the other cytokines
evaluated.
3.2. Severe preeclamptic women display an outstanding pro-
inﬂammatory ‘‘cytokine signature’’ while an overall regulatory state is
the hallmark of normotensive pregnancy
In order to assemble the cytokine signature of each study group,
the global median plasma values for each cytokine was ﬁrst calcu-
lated to establish the cut-off used to segregated women with
‘‘Low’’ or ‘‘High’’ cytokines levels, as illustrated in Fig. 2A (IL-
8 = 2.75; IL-6 = 9.31; IL-1b = 4.39; TNF-a = 4.03; IL-12 = 7.77;ve pregnant Preeclamptic women P value
26 (7.1) 0.281
33 (22–40) 0.799
–26.70) 23.94 (21.69–28.03)a 0.016*
.4) 12.7 (2,1–76.1) 0.033*
) 170 (130–220)a,c <0.001*
110 (90–150)a,c <0.001*
diastolic blood pressure; BMI: body mass index (–): does not apply.
ey post-test.
formed by Kruskal–Wallis followed by Dunn’s post-test.
nant vs normotensive pregnant; c normotensive pregnant vs PE.
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Fig. 1. Cytokine plasma levels in preeclamptic women ( ) as compared to normotensive pregnant ( ) and non-pregnant women ( ). Plasma levels of pro-inﬂammatory
(IL-8, IL-6, IL-1b, TNF-a, IL-12, and IFN-c) and regulatory (IL-4, IL-5, and IL-10) cytokines were determined by cytometric beads array. Results are expressed in mean
ﬂuorescence intensity (MFI) data are presented in a box plot format. The lines stretch from the 10th percentile to the upper 90th percentile, highlighting the outliers (d). The
median is shown as a line across the box. Statistical analysis was performed by non-parametric Mann–Whitney test. Signiﬁcant differences at P < 0.05 are highlighted by
connecting lines.
M.B. Pinheiro et al. / Cytokine 62 (2013) 165–173 167IFN-c = 3.79; IL-4 = 1.40; IL-5 = 3.13; IL-10 = 4.70, all expressed in
MFI). Using these values, each woman received a tag for each cyto-
kine. Following, diagrams were used to assemble the pro-inﬂam-
matory and regulatory proﬁles and to calculate the frequency (%)
of women showing ‘‘High cytokine levels’’ as showed in the
Fig. 2B. The frequency of women with high cytokine levels was fur-
ther compiled to establish the cytokine ascendant proﬁle, referred
as ‘‘cytokine signatures’’ for each study group (Fig. 3A). Data anal-
ysis was carried out considering relevant only the cytokine fre-
quencies above the 50th percentile. Using this criterion, the IL-4
was the only relevant element in the ‘‘cytokine signature’’ of the
non-pregnant women. On the other hand, normotensive pregnant
showed an outstanding frequency of regulatory cytokines IL-4,
IL-5 and IL-10 along with borderline inﬂammatory IL-1b. More-
over, cytokine signatures of severe preeclamptic women showed
a predominance of pro-inﬂammatory cytokines, including IL-8,
IL-6, IL-1b, TNF-a, IL-12 and IFN-c with IL-4 as the only one regu-
latory cytokine. The overlay of ascendant ‘‘cytokine signatures’’
from the three study groups was further used to illustrate these
ﬁndings (Fig. 3B). Alternatively, the ascendant ‘‘cytokine signature’’
from the non-pregnant group was used as a reference curve for
comparative analysis with the normotensive and severe PE groups
(Fig. 4A). Considering relevant only the cytokine frequencies above
the 50th percentile, data analysis demonstrated that the normo-tensive group displayed elevated percentage of women with high
levels of IL-1b, IL-5 and IL-10 as compared to the non-pregnant
group. On the other hand, severe preeclamptic group showed en-
hanced frequency of pro-inﬂammatory cytokines, including IL-8,
IL-6, IL-1b, TNF-a, IL-12, and IFN-c as compared to the non-preg-
nant women group (Fig. 4A).
Additionally, the severe preeclamptic group showed higher fre-
quency of pro-inﬂammatory cytokines, including IL-8, IL-6, TNF-a,
IL-12 and IFN-c along with lower frequency of regulatory cytokines
(IL-5 and IL-10) when the ascendant ‘‘cytokine signature’’ from the
normotensive group was used as a reference curve for comparative
analysis (Fig. 4B).
3.3. Deviation in the ‘‘IL-8  IL-6’’ axis towards IFN-c is the hallmark
of the cytokine network correlation in preeclamptic women
The dynamic connections within the pro-inﬂammatory cyto-
kine network were further evaluated using the correlation analysis
as a tool to identify any shift in preeclamptic women aside from
the normal pregnancy course (Fig. 5). Our data pointed out to a
universal axis of positive correlation between IL-8 and IL-6 in all
studied groups. In non-pregnant women this axis also included
an effective correlation with TNF-a, whereas in normotensive
pregnant this common axis shifted towards a connection with
(A) (B)
Fig. 2. Plasma cytokine cut-off and frequency of women with High levels of plasma cytokine amongst preeclamptic women, normotensive pregnant and non-pregnant
women. (A) Scatter graphs employed to establish the concept of Low cytokine producers (s < global median), High pro-inﬂammatory cytokine producers for IL-8, IL-6, IL-1b,
TNF-a, IL-12, IFN-c (dP global median) and High regulatory cytokine producers for IL-4, IL-5 and IL-10 ( P global median), all expressed in Mean ﬂuorescence Intensity –
MFI). Low ( for all cytokines) and High ( for pro-inﬂammatory and for regulatory) cytokine producers were tagged for further frequency analysis. (B) Multi-cytokine
diagrams used to quantify the frequency of women with high levels of cytokines in all studied groups. Relevant frequencies, considered for values above the 50th percentile
are highlighted in bold underline format.
168 M.B. Pinheiro et al. / Cytokine 62 (2013) 165–173IL-1b. Although the IL-1b connection is somehow preserved in pre-
eclamptic women, a deviation forward IFN-c appears as a satellite
link reinforcing the pro-inﬂammatory cytokine network at this
clinical condition.
4. Discussion
Our data demonstrated high levels of IL-8 in preeclamptic wo-
men comparing to normotensive pregnant. According, several
studies showed higher IL-8 plasma levels in preeclamptic women
[6,7,15]. Likewise, increased IL-8 production by maternal periphe-
ral blood mononuclear cells (PBMCs) in PE has been demonstrated
[16–19]. Production of IL-8 by neutrophils that inﬁltrate the vascu-
lature in women with PE [20,21] would provide a chemotactic gra-
dient to attract more neutrophils. These cells can adhere on the
endothelium, inﬁltrate into the intimal space and release reactive
oxygen species, myeloperoxidase, matrix metalloproteinase 8 and
thromboxane, causing inﬂammation [22]. In this way, IL-8 seems
to have a pivotal role in PE pathogenesis and severity.
Moreover, our data demonstrated high levels of IL-6 in pre-
eclamptic women comparing to normotensive pregnant. Similarly,
a recent metanalysis has highlighted the role of IL-6 in PE [13]. IL-6
is a multifunctional cytokine that regulates hematopoiesis, as well
as the acute-phase reaction and modulates both pro- andanti-inﬂammatory events [23]. Chronic infusion of this cytokine
to pregnant rats in vivo has caused hypertension and proteinuria,
the two classical symptoms of PE [24,25]. Endothelium activation
is associated with PE, which justiﬁes, at least in part, the clinical
signs of the disease [26]. As it is known that IL-6 interferes in endo-
thelial cell function [27], a role of this cytokine in PE may be admit-
ted. It has been shown that an increased level of circulating IL-6
levels occur in PE women regardless the gestational age (early or
late) of PE onset [28]. These results suggested that an excessive
maternal inﬂammatory response is associated with this disease.
TNF-a is a powerful pro-inﬂammatory cytokine and it is found
in human placental and uterine cells, both early and late in gesta-
tion [29]. Several studies have reported elevated TNF-a maternal
circulating levels in PE, suggesting that TNF-a could be involved
in the pathogenesis of this disease [13,19,30–33]. However, like-
wise our data, other studies have not reported signiﬁcant differ-
ences in TNF-a maternal levels compared to normotensive
pregnant [16,17,34,35].
It is known that IL-6 can inhibit IL-1 and TNF-a [23,36], which
could be one explanation for a lack of differences for the latter two
cytokines between preeclamptic women and normotensive preg-
nant. Another justiﬁcation may be due to the relatively short half-
life of the cytokines, as well as possible transient and episodic re-
lease, which may result in considerable plasma levels variation not
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Fig. 3. ‘‘Cytokine signatures’’ preeclamptic women, normotensive pregnant and non-pregnant women. (A) The ascendant frequency of women with High levels of plasma
cytokine was assembled and data expressed by bars graphs. Relevant frequencies, considered for values above the 50th percentile (cut-off dotted line) are highlighted by . (B)
The cytokine signatures were further overlaid for preeclamptic women ( ), normotensive pregnant ( ) and non-pregnant women (h) to identify relevant elements in the
cytokine signature that emerge above the 50th percentile (cut-off dotted line). These elements are highlighted in the bottom ‘‘X axis’’ by rectangles.
M.B. Pinheiro et al. / Cytokine 62 (2013) 165–173 169shown in a single blood sample. Although IL-1 and TNF-a were not
increased in preeclamptic women, it is known that the endothelium
in some patientsmight bemore sensitive to activation by cytokines,
which could lead to injuries evenwhen the cytokines levels are nor-
mal [17]. Little is known about the relationship between the cyto-
kine proﬁle and distinct clinical forms of PE (mild and severe),
mainly due to insufﬁcient studies on this matter. A recent report
has demonstrated that there are no signiﬁcant differences between
the serum levels of TNF-a and IL-6 betweenmild and severe PE [37].In agreement with our ﬁndings, several studies have been dem-
onstrated high IFN-c levels in preeclamptic women [5–7,38,39].
However, other studies have not found an increase in this cytokine
levels in preeclamptic women compared to normotensive pregnant
[4,17]. The role of IFN-c during normal pregnancy is still controver-
sial. For instance, primiparous IFN-c knockout mice experience fe-
tal loss [40], and this cytokine can trigger spiral artery
modiﬁcations [41]. However, these results were not obtained in
multiparous mice.
(A)
(B)
Fig. 4. Comparative analysis of the cytokine signatures of preeclamptic women as compared to normotensive pregnant ( ) and non-pregnant women. (A) The ascendant
frequency of women with high cytokine plasma levels was assembled for the non-pregnant women as demonstrated by bars graphs ( ) and by the ascendant cytokine curve
for non-pregnant women (—h—). Comparative analysis with normotensive pregnant and preeclamptic women ( ) was further performed taking the ascendant cytokine for
non-pregnant women (—h—) as reference. (B) The ascendant frequency of women with high cytokine plasma levels was also assembled for the normotensive pregnant
( ) and used for comparative analysis with the cytokine proﬁle of preeclamptic women. Dotted lines indicate the 50th percentiles used as the cut-off to identify
relevant elements, highlighted by " and ; for increased or decreased frequencies, respectively.
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normotensive pregnant compared to preeclamptic women and
non-pregnant women (Fig. 1). Previous studies reported high levels
of IL-10 in healthy pregnant [9,42–45], suggesting that successful
pregnancy reﬂects a predominance of regulatory cytokine. Studies
inmice revealed that IL-10 deﬁciency in early pregnancy affects tro-
phoblast growth and differentiation, causing placental failure and
abortion [46]. IL-10 also increases the resistance of trophoblasts to
Fas-mediated apoptosis [47]. Inhibition of IL-10 by passive immuni-
zation (with monoclonal antibody to IL-10) during early gestation
increases blood pressure in pregnant baboons [48]. Therefore, it
has been suggested that decreased IL-10 production is associated
with pregnancy disorders including PE [32,49,50].
Contrarily to our data other studies demonstrated an increase in
IL-10 levels in preeclamptic women compared to normotensive
pregnant [7,13,51,52]. The interpretation of IL-10 results should
be cautiously done. As the half-life of this cytokine is very short,
it is not consistently present in circulation. Therefore, a single
blood sample may fail to detect a sporadic raise or decline in this
cytokine level. Besides, other factors as the effect of gestational
age at the time of sample collection, the inﬂuence of body massindex and the assay sensitivity may also explain the divergences
in IL-10 levels among studies [53]. In conclusion, there is no con-
sensus regarding IL-10 production in PE.
IL-1b, IL-12, IL-4, and IL-5 were successfully detected in our
studied groups but no difference was found comparing preeclamp-
tic women and normotensive pregnant. Although this might repre-
sent the real condition in vivo, such results must be carefully
interpreted. A speculative explanation could be related to the par-
acrine action of T-cell cytokines, which are quickly bound to recep-
tors on neighboring cells, not being available in circulation. As a
result, these cytokines plasma levels in both groups may be similar,
even though an increased production has occurred in PE [17].
The cytokine proﬁle from the each group as a whole showed
that normotensive pregnant presented an outstanding frequency
of regulatory cytokines IL-4, IL-5 and IL-10, along with borderline
inﬂammatory IL-1b, while for non-pregnant women only IL-4
was increased (Fig. 3). On the other hand, severe preeclamptic wo-
men showed a predominance of pro-inﬂammatory cytokines,
including IL-8, IL-6, IL-1b, TNF-a, IL-12 and IFN-c, while IL-4 was
the only increased regulatory cytokine. These data suggest that se-
vere PE is associated with an exacerbated inﬂammatory condition,
(A)
(B)
Fig. 5. Correlations analysis of pro-inﬂammatory cytokines in preeclampticwomenas compared to normotensive pregnant andnon-pregnantwomen. (A) Spearman correlation
graphs illustrate the signiﬁcant connectionswithin the pro-inﬂammatory cytokine network. (B) The grayscale diagrampoint out the universal connections between IL-8 and IL-6
in all studied groups ( ). An effective association with TNF-a is observed in non-pregnant women ( ), whereas a shift towards IL-1b is observed during pregnancy ( ) as
observed in normotensive pregnant and preeclamptic women. Deviation towards a satellite connection with IFN-c ( ) is the hallmark of preeclamptic women. The cytokine
network links are represented by connecting lines for each studied groups (---- for non-pregnant women; –- for normotensive pregnant and — for preeclamptic women).
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nates, as showed in Fig. 3.
In order to compare the inﬂammatory status between non-
pregnant women vs normotensive pregnant or vs the severe PE
group, the ascendant ‘‘cytokine signature’’ from the non-pregnant
group was used as a reference curve (Fig. 4A). In this way, only
the cytokine frequencies above the 50th percentile were consid-
ered. The ascendant ‘‘cytokine signature’’ analysis revealed that
the normotensive group displayed an elevated percentage of wo-
men with high levels of IL-1b, IL-5 and IL-10, when compared to
the non-pregnant group. These data suggest that healthy preg-
nancy is characterized by a predominant regulatory cytokine pro-
ﬁle (Fig. 4A). Contrarily, the severe preeclamptic group showed a
higher frequency of pro-inﬂammatory cytokines, including IL-8,
IL-6, IL-1b, TNF-a, IL-12, and IFN-c, comparing to the non-pregnant
group (Fig. 4A). In physiological conditions, the cytokines balance
is signiﬁcantly altered in pregnancy by the placenta, since proges-
terone and cytokines modulate the immune cells by regulatory re-
sponse [3]. The shift away from pro-inﬂammatory cytokine
production during pregnancy is beneﬁcial for this condition, since
pro-inﬂammatory cytokines, especially IFN-c and TNF-a, are
harmful for pregnancy. Experimental studies revealed that these
cytokines inhibited embryonic and fetal development [54,55] and
interrupted pregnancy when injected into pregnant mice [54]. Sev-
eral groups have shown that, particularly in the third trimester of
human pregnancy, the ratio of pro-inﬂammatory/regulatory cyto-
kines production by peripheral T-lymphocytes is decreased, as
compared to non-pregnant women [56–60]. However, there is no
consensus if this decreased cytokines pro-inﬂammatory/regulatory
ratio is due to a decreased production of pro-inﬂammatory cyto-
kines [59,60] or to an increased production of regulatory cytokines
(IL-4, IL-5, IL-9, IL-10) [54]. Our results suggest an increased pro-
duction of regulatory cytokines and a normal production of inﬂam-
matory cytokines in normotensive pregnant women.
In order to compare the inﬂammatory status between normo-
tensive pregnant vs the severe PE group, the ascendant ‘‘cytokine
signature’’ from the normotensive pregnant group was used as a
reference curve (Fig. 4B). The severe preeclamptic group showed
higher frequency of pro-inﬂammatory cytokines, including IL-8,
IL-6, TNF-a, IL-12 and IFN-c, along with lower frequency of regula-
tory cytokines (IL-5 and IL-10). Once more, our data suggest that
severe PE evolves a high pro-inﬂammatory response and low par-
ticipation of regulatory cytokines. Accordingly to our data, Sargent
et al. has suggested that PE does not present a shift toward modu-
lated response and, as a consequence, pro-inﬂammatory responses
are not suppressed [61].
Correlation analysis was used as a tool to identify the dynamic
connections within the pro-inﬂammatory cytokine network in pre-
eclamptic women (Fig. 5). For the three groups studied, a positive
correlation between IL-6 and IL-8 was found, suggesting that these
cytokines participate in the physiological mechanisms. Normoten-
sive pregnant and preeclamptic women showed a positive correla-
tion between IL-8 and IL-1b, suggesting that these cytokines are
normally expressed in pregnancy. However, a positive correlation
between IL-6 and IL-1b was observed in normotensive pregnant,
but not in preeclamptic women. On the other hand, a positive cor-
relation between IL-8 and IFN-cwas observed in preeclamptic wo-
men, but not in normotensive pregnant. It is possible to infer that
this change in cytokines proﬁle can be an important factor for the
development of PE. Besides, altered cytokine levels may have a di-
rect effect on maternal systemic vasculature. In agreement with
our data, Kalinderis et al. did not ﬁnd a positive correlation be-
tween IL-6 and IL-1b in preeclamptic women [62].
In summary, our data showed that elevated levels of pro-
inﬂammatory cytokines in the maternal circulation, with a
deviation in the ‘‘IL-8  IL-6’’ axis towards IFN-c might drive thecytokine network in preeclamptic women towards an excessive
systemic inﬂammatory state.Acknowledgements
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